Knee Osteoarthritis (Medial Compartment)

Comprehensive Clinical Guide: Medial Compartment Knee Osteoarthritis (MCOA)

1. Introduction and Clinical Overview

Medial Compartment Knee Osteoarthritis (MCOA) represents the most prevalent phenotype of degenerative joint disease affecting the human knee. Anatomically, the knee is divided into three primary compartments: the medial tibiofemoral, the lateral tibiofemoral, and the patellofemoral. MCOA specifically involves the progressive degradation of articular cartilage, subchondral bone remodeling, and meniscal attrition within the medial aspect of the joint.

Because the medial compartment bears approximately 60% to 80% of the body’s weight during the stance phase of gait, it is disproportionately susceptible to mechanical wear. MCOA is characterized by a gradual onset of chronic pain, stiffness, and mechanical axis deviation, typically manifesting as a varus (bow-legged) deformity. For clinicians, early identification and management are critical to preventing the secondary sequelae of gait compensation and long-term functional disability.

2. Etiology and Pathophysiology

The pathophysiology of MCOA is multifactorial, involving a synergistic interplay between mechanical, biological, and metabolic factors.

The Mechanical Axis

The primary driver of MCOA is the shift in the mechanical axis of the lower extremity. When the knee joint shifts into a varus alignment, the ground reaction force vector passes medial to the center of the knee, significantly increasing the compressive load on the medial femoral condyle and the medial tibial plateau.

Key Pathophysiological Mechanisms

• Chondrocyte Senescence: A decline in the synthetic activity of chondrocytes leads to an imbalance between extracellular matrix (ECM) synthesis and degradation.
• Matrix Metalloproteinase (MMP) Activation: Upregulation of MMPs and aggrecanases leads to the enzymatic breakdown of Type II collagen and proteoglycans.
• Subchondral Bone Remodeling: Increased mechanical stress induces micro-fractures in the subchondral bone, leading to sclerosis, osteophyte formation, and the development of subchondral bone cysts (geodes).
• Synovial Inflammation: Chronic low-grade synovitis releases pro-inflammatory cytokines (IL-1β, TNF-α), which further stimulate cartilage degradation.

3. Clinical Staging and Grading

Clinical and radiographic staging is essential for prognosis and surgical planning. The Kellgren-Lawrence (K-L) Grading Scale remains the gold standard for radiographic assessment.

4. Clinical Presentation and Diagnostic Evaluation

Standard Presentation

Patients typically present in the 5th or 6th decade of life. The clinical hallmark is medial joint line tenderness and localized pain exacerbated by weight-bearing activities.

• Morning Stiffness: Usually lasts <30 minutes.
• Mechanical Symptoms: Clicking, catching, or locking (often associated with medial meniscus degeneration).
• Gait Abnormalities: Patients may exhibit an "antalgic gait" or an "outward thrust" during the stance phase.
• Varus Deformity: Observable bow-legged appearance upon standing.

Diagnostic Testing

1. Weight-Bearing Radiographs: AP, lateral, and sunrise views are mandatory. A "Rosenberg view" (45-degree flexion) is often more sensitive for detecting early medial joint space narrowing.
2. MRI: Indicated if there is suspicion of meniscal tears, bone marrow lesions (BMLs), or ligamentous instability. MRI is superior for identifying subchondral edema, a known predictor of rapid pain progression.
3. Physical Exam Maneuvers:
   • Joint Line Tenderness: High sensitivity for medial compartment pathology.
   • Varus Stress Test: To assess the integrity of the lateral collateral ligament (often lax in severe varus cases).
   • Range of Motion (ROM): Often reveals a fixed flexion contracture.

5. Differential Diagnosis

It is critical to distinguish MCOA from other sources of knee pain to ensure appropriate management:

• Medial Meniscal Tear: Can present with similar joint line tenderness but usually has a more acute onset.
• Pes Anserine Bursitis: Localized tenderness inferior to the medial joint line; less likely to cause deep intra-articular pain.
• Medial Collateral Ligament (MCL) Injury: Usually linked to a specific trauma; presents with tenderness over the ligamentous insertion.
• Avascular Necrosis (AVN): Often presents with more severe, nocturnal pain; MRI is diagnostic.
• Referred Pain: Hip pathology (e.g., hip OA) can frequently manifest as referred knee pain.

6. Management Strategies: Risks and Contraindications

Conservative Management

• Activity Modification: Avoid high-impact activities (running, jumping).
• Pharmacology: NSAIDs (topical or oral) are first-line. Contraindications: History of GI bleeding, renal insufficiency, or cardiovascular disease (for systemic NSAIDs).
• Viscosupplementation: Intra-articular hyaluronic acid injections. Risks: Post-injection flare, rare septic arthritis.
• Bracing: Offloader braces are specifically designed to shift the load from the medial to the lateral compartment.

Surgical Interventions

• High Tibial Osteotomy (HTO): Indicated for younger, active patients with unicompartmental MCOA and varus alignment.
• Unicompartmental Knee Arthroplasty (UKA): A "resurfacing" procedure for isolated medial disease.
• Total Knee Arthroplasty (TKA): The gold standard for end-stage (K-L Grade 4) disease.

7. Long-Term Prognosis

The natural history of MCOA is typically progressive. However, prognosis is highly variable and depends on:
1. Body Mass Index (BMI): Obesity is the single largest modifiable risk factor. Weight loss significantly reduces the compressive load on the medial compartment.
2. Muscle Strength: Quadriceps weakness is associated with faster disease progression.
3. Alignment: The degree of varus deformity at the time of diagnosis is a strong predictor of the rate of joint space collapse.

8. Massive FAQ Section

1. Is MCOA reversible?
No, articular cartilage has limited regenerative capacity. Current treatments focus on symptom management, slowing progression, and restoring function.

2. Does running cause MCOA?
While moderate running is not definitively linked to OA in healthy knees, high-impact activities in patients with pre-existing joint damage or malalignment can accelerate the degenerative process.

3. What is the role of the medial meniscus?
The medial meniscus acts as a shock absorber. In MCOA, the meniscus often undergoes "extrusion," losing its ability to distribute load, which accelerates cartilage wear.

4. When is surgery recommended?
Surgery is considered when conservative measures (PT, NSAIDs, bracing) fail to provide adequate pain relief or when the patient's quality of life is severely impacted.

5. Are supplements like Glucosamine effective?
Clinical evidence is mixed. While some patients report subjective improvement, high-quality meta-analyses suggest that the effect is often no better than a placebo.

6. Can physical therapy cure the condition?
Physical therapy cannot "cure" OA, but it is highly effective at strengthening the musculature around the knee, which stabilizes the joint and reduces pain.

7. What is an "Offloader" brace?
It is a specialized brace that exerts a lateral force on the knee, effectively "opening" the medial joint space to reduce friction and pressure on the damaged compartment.

8. Is walking good for MCOA?
Low-impact movement is essential. It promotes synovial fluid circulation, which provides nutrition to the cartilage. However, walking should be balanced with rest if pain flares.

9. Why is the medial side affected more often than the lateral?
The medial tibial plateau is larger and more concave, and the natural mechanical alignment of the limb puts higher stress on the medial side during the gait cycle.

10. What are the signs of a "flare-up"?
Increased swelling (effusion), warmth, nocturnal pain, and a sudden decrease in range of motion are clinical indicators of an inflammatory flare-up.

9. Clinical Summary Table: Treatment Hierarchy

Disclaimer: This guide is for educational purposes for healthcare professionals and students. It does not replace individualized clinical judgment or institutional protocols. Always consult with an orthopedic surgeon for specific patient management.